In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis

Detalhes bibliográficos
Autor(a) principal: Cabral, Eduardo Ramos Martins
Data de Publicação: 2019
Outros Autores: Moraes, Dayane, Levenhagen, Marcelo Arantes, Matos, Ricardo Alexandre Figueiredo de, Costa-Cruz, Julia Maria, Rodrigues, Rosângela Maria
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista do Instituto de Medicina Tropical de São Paulo
Texto Completo: https://www.revistas.usp.br/rimtsp/article/view/164174
Resumo: Strongyloidiasis is a human parasitic disease caused by the helminth Strongyloides stercoralis whose treatment is particularly difficult in immunosuppressed patients due to their low responsiveness to conventional therapy. Carica papaya and its isolated compounds benzyl isothiocyanate, carpaine and carpasemine are promising compound for the treatment of Strongyloides infections due to their anthelmintic action. This study aims to examine the in vitro ovicidal and larvicidal activity of C. papaya seed hexane extract against Strongyloides venezuelensis, using egg hatching tests and larval motility tests as efficiency markers. The crude extract at the concentrations of 566 – 0.0566 mg/mL or the control with albendazole (0.025 mg/mL) and negative controls (water and PBS) were incubated with an equal volume of egg suspension (± 50 specimens) followed by counting of the specimens after 48 h. The same extract and dilutions were added to L3 larvae suspensions (±50 specimens) followed by analysis of larvae viability after 24, 48, and 72 h. The extract inhibited egg hatching with high efficiency at concentrations of 56.6 mg/mL (95.74%) and 5.66 mg/mL (92.16%). At the concentrations of 566 mg/mL (100%) and 56.66 mg/mL (97.32%), the extract inhibited larval motility as effectively as ivermectin (0.316 mg/mL; 100%), and more effectively than the other dilutions and the negative controls. The larvicidal effect depended on the extract concentration, but not on the treatment period. Therefore, C. papaya seed hexane extract has anthelmintic potential against S. venezuelensis and is a promising compound for the development of phytotherapies to treat strongyloidiasis.
id IMT-1_a5b332bb8cda3eeee1343fef7442297d
oai_identifier_str oai:revistas.usp.br:article/164174
network_acronym_str IMT-1
network_name_str Revista do Instituto de Medicina Tropical de São Paulo
repository_id_str
spelling In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensisCarica papayaSeed extractEgg hatching testLarval motility testAnthelmintic activityStrongyloidiasisStrongyloidesstercoralisStrongyloides venezuelensisStrongyloidiasis is a human parasitic disease caused by the helminth Strongyloides stercoralis whose treatment is particularly difficult in immunosuppressed patients due to their low responsiveness to conventional therapy. Carica papaya and its isolated compounds benzyl isothiocyanate, carpaine and carpasemine are promising compound for the treatment of Strongyloides infections due to their anthelmintic action. This study aims to examine the in vitro ovicidal and larvicidal activity of C. papaya seed hexane extract against Strongyloides venezuelensis, using egg hatching tests and larval motility tests as efficiency markers. The crude extract at the concentrations of 566 – 0.0566 mg/mL or the control with albendazole (0.025 mg/mL) and negative controls (water and PBS) were incubated with an equal volume of egg suspension (± 50 specimens) followed by counting of the specimens after 48 h. The same extract and dilutions were added to L3 larvae suspensions (±50 specimens) followed by analysis of larvae viability after 24, 48, and 72 h. The extract inhibited egg hatching with high efficiency at concentrations of 56.6 mg/mL (95.74%) and 5.66 mg/mL (92.16%). At the concentrations of 566 mg/mL (100%) and 56.66 mg/mL (97.32%), the extract inhibited larval motility as effectively as ivermectin (0.316 mg/mL; 100%), and more effectively than the other dilutions and the negative controls. The larvicidal effect depended on the extract concentration, but not on the treatment period. Therefore, C. papaya seed hexane extract has anthelmintic potential against S. venezuelensis and is a promising compound for the development of phytotherapies to treat strongyloidiasis.Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo2019-11-18info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/xmlhttps://www.revistas.usp.br/rimtsp/article/view/16417410.1590/S1678-9946201961059Revista do Instituto de Medicina Tropical de São Paulo; Vol. 61 (2019); e59Revista do Instituto de Medicina Tropical de São Paulo; Vol. 61 (2019); e59Revista do Instituto de Medicina Tropical de São Paulo; v. 61 (2019); e591678-99460036-4665reponame:Revista do Instituto de Medicina Tropical de São Pauloinstname:Instituto de Medicina Tropical (IMT)instacron:IMTenghttps://www.revistas.usp.br/rimtsp/article/view/164174/157567https://www.revistas.usp.br/rimtsp/article/view/164174/157568Copyright (c) 2019 Revista do Instituto de Medicina Tropical de São Pauloinfo:eu-repo/semantics/openAccessCabral, Eduardo Ramos MartinsMoraes, DayaneLevenhagen, Marcelo ArantesMatos, Ricardo Alexandre Figueiredo deCosta-Cruz, Julia MariaRodrigues, Rosângela Maria2019-11-18T17:29:33Zoai:revistas.usp.br:article/164174Revistahttp://www.revistas.usp.br/rimtsp/indexPUBhttps://www.revistas.usp.br/rimtsp/oai||revimtsp@usp.br1678-99460036-4665opendoar:2022-12-13T16:52:50.584491Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)true
dc.title.none.fl_str_mv In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis
title In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis
spellingShingle In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis
Cabral, Eduardo Ramos Martins
Carica papaya
Seed extract
Egg hatching test
Larval motility test
Anthelmintic activity
Strongyloidiasis
Strongyloidesstercoralis
Strongyloides venezuelensis
title_short In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis
title_full In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis
title_fullStr In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis
title_full_unstemmed In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis
title_sort In vitro ovicidal and larvicidal activity of Carica papaya seed hexane extract against Strongyloides venezuelensis
author Cabral, Eduardo Ramos Martins
author_facet Cabral, Eduardo Ramos Martins
Moraes, Dayane
Levenhagen, Marcelo Arantes
Matos, Ricardo Alexandre Figueiredo de
Costa-Cruz, Julia Maria
Rodrigues, Rosângela Maria
author_role author
author2 Moraes, Dayane
Levenhagen, Marcelo Arantes
Matos, Ricardo Alexandre Figueiredo de
Costa-Cruz, Julia Maria
Rodrigues, Rosângela Maria
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Cabral, Eduardo Ramos Martins
Moraes, Dayane
Levenhagen, Marcelo Arantes
Matos, Ricardo Alexandre Figueiredo de
Costa-Cruz, Julia Maria
Rodrigues, Rosângela Maria
dc.subject.por.fl_str_mv Carica papaya
Seed extract
Egg hatching test
Larval motility test
Anthelmintic activity
Strongyloidiasis
Strongyloidesstercoralis
Strongyloides venezuelensis
topic Carica papaya
Seed extract
Egg hatching test
Larval motility test
Anthelmintic activity
Strongyloidiasis
Strongyloidesstercoralis
Strongyloides venezuelensis
description Strongyloidiasis is a human parasitic disease caused by the helminth Strongyloides stercoralis whose treatment is particularly difficult in immunosuppressed patients due to their low responsiveness to conventional therapy. Carica papaya and its isolated compounds benzyl isothiocyanate, carpaine and carpasemine are promising compound for the treatment of Strongyloides infections due to their anthelmintic action. This study aims to examine the in vitro ovicidal and larvicidal activity of C. papaya seed hexane extract against Strongyloides venezuelensis, using egg hatching tests and larval motility tests as efficiency markers. The crude extract at the concentrations of 566 – 0.0566 mg/mL or the control with albendazole (0.025 mg/mL) and negative controls (water and PBS) were incubated with an equal volume of egg suspension (± 50 specimens) followed by counting of the specimens after 48 h. The same extract and dilutions were added to L3 larvae suspensions (±50 specimens) followed by analysis of larvae viability after 24, 48, and 72 h. The extract inhibited egg hatching with high efficiency at concentrations of 56.6 mg/mL (95.74%) and 5.66 mg/mL (92.16%). At the concentrations of 566 mg/mL (100%) and 56.66 mg/mL (97.32%), the extract inhibited larval motility as effectively as ivermectin (0.316 mg/mL; 100%), and more effectively than the other dilutions and the negative controls. The larvicidal effect depended on the extract concentration, but not on the treatment period. Therefore, C. papaya seed hexane extract has anthelmintic potential against S. venezuelensis and is a promising compound for the development of phytotherapies to treat strongyloidiasis.
publishDate 2019
dc.date.none.fl_str_mv 2019-11-18
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/164174
10.1590/S1678-9946201961059
url https://www.revistas.usp.br/rimtsp/article/view/164174
identifier_str_mv 10.1590/S1678-9946201961059
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/rimtsp/article/view/164174/157567
https://www.revistas.usp.br/rimtsp/article/view/164174/157568
dc.rights.driver.fl_str_mv Copyright (c) 2019 Revista do Instituto de Medicina Tropical de São Paulo
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Revista do Instituto de Medicina Tropical de São Paulo
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/xml
dc.publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
publisher.none.fl_str_mv Universidade de São Paulo. Instituto de Medicina Tropical de São Paulo
dc.source.none.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo; Vol. 61 (2019); e59
Revista do Instituto de Medicina Tropical de São Paulo; Vol. 61 (2019); e59
Revista do Instituto de Medicina Tropical de São Paulo; v. 61 (2019); e59
1678-9946
0036-4665
reponame:Revista do Instituto de Medicina Tropical de São Paulo
instname:Instituto de Medicina Tropical (IMT)
instacron:IMT
instname_str Instituto de Medicina Tropical (IMT)
instacron_str IMT
institution IMT
reponame_str Revista do Instituto de Medicina Tropical de São Paulo
collection Revista do Instituto de Medicina Tropical de São Paulo
repository.name.fl_str_mv Revista do Instituto de Medicina Tropical de São Paulo - Instituto de Medicina Tropical (IMT)
repository.mail.fl_str_mv ||revimtsp@usp.br
_version_ 1798951652627054592